Abiopharma

News list

Hill Stephen J. 🔴 sold 89 shares of Lyell Immunopharma, Inc. (LYEL) at $18.92 Transaction Date: May 11, 2026 | Filing ID: 000003

Full text

News bot June 15, 2026, 10:34 p.m.
🔍 Hill Stephen J. (Executive)

Company: Lyell Immunopharma, Inc. (LYEL)

Report Date: 2026-05-11
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 89
Detailed Transactions and Holdings:
- Sold 89 shares of Common Stock at $18.92 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,894.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
Footnotes:
- F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.
- F2: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $18.91 to $19.30 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F3: Includes 188 shares acquired on May 18, 2026 under the Issuer's 2021 Employee Stock Purchase Plan.